Preparation, characterization and evaluation of Ginkgo biloba solid lipid nanoparticles

Objective(s): In this work, Ginkgo biloba extract (GBE) loaded solid lipid nanoparticles (SLNs) were synthesized via high pressure homogenization method and their physicochemical properties, as well as cytotoxicity and antibacterial activities were evaluated.Methods: Ginkgo biloba extract SLNs (GBE-SLNs) were prepared using high pressure homogenization method. The morphology and size of SLNs were evaluated by scanning electron microscopy (SEM) and dynamic light scattering (DLS) techniques. The drug release of SLNs was also investigated using synthetic dialysis membrane. The antibacterial activity of nanoparticles was tested against both gram negative and gram positive bacteria strains. The probability of having toxicity of SLNs was studied on the rabbits.Results: The spherical structure of GBE-SLNs was confirmed by SEM images. The mean particle size of the obtained SLNs was ranging from 104 to 621 nm for different formulations using DLS technique. An in-vitro study of synthesized SLNs illustrated that the percentage of ginkgo biloba released from the solid lipid nanoparticles was 85% of loaded GBE after 72 hours. There was no report of significant skin toxicity via in-vivo studies.Conclusions: According to the above results, SLNs loaded with ginkgo extract showed acceptable particle size and shape, suitable loading of active substance and sustained release profile as well as appropriate antimicrobial effects without any significant skin toxicity.

[1]  Chengzhang Wang,et al.  Polyprenols of Ginkgo biloba Enhance Antibacterial Activity of Five Classes of Antibiotics , 2016, BioMed research international.

[2]  M. Ardjmand,et al.  Sustained release Curcumin loaded Solid Lipid Nanoparticles , 2016, Advanced pharmaceutical bulletin.

[3]  S. C. Sati,et al.  Antibacterial Activities of Ginkgo biloba L. Leaf Extracts , 2011, TheScientificWorldJournal.

[4]  J. Varshosaz,et al.  Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles , 2010, International journal of nanomedicine.

[5]  Jie Xu,et al.  Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. , 2009, Chemico-biological interactions.

[6]  M. Khoshayand,et al.  Development and optimization of solid lipid nanoparticles of amikacin by central composite design , 2009, Journal of liposome research.

[7]  T. V. van Beek,et al.  Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. , 2009, Journal of chromatography. A.

[8]  S. Bent,et al.  Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation , 2008, Journal of General Internal Medicine.

[9]  Jin Sun,et al.  Self-Emulsifying Drug Delivery Systems for Improving Oral Absorption of Ginkgo Biloba Extracts , 2008 .

[10]  K. Harding,et al.  Bacteria and wound healing , 2004, Current opinion in infectious diseases.

[11]  P. Bars.  Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders. , 2003 .

[12]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[13]  C. Unger,et al.  Phase II Study of Combined 5‐Fluorouracil/ Ginkgo biloba Extract (GBE 761 ONC) Therapy in 5‐Fluorouracil Pretreated Patients with Advanced Colorectal Cancer , 2001, Phytotherapy research : PTR.

[14]  Shelley Drew,et al.  Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial , 2001, BMJ : British Medical Journal.

[15]  K. Wesnes,et al.  The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers , 2000, Psychopharmacology.

[16]  F. Meloni,et al.  Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. , 1998, Advances in Therapy.

[17]  M. Kieser,et al.  Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial. , 1998, VASA. Zeitschrift fur Gefasskrankheiten.

[18]  A. Cohen,et al.  Ginkgo biloba for antidepressant-induced sexual dysfunction. , 1998, Journal of sex & marital therapy.

[19]  Turan M. Itil,et al.  A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .

[20]  A. Schatzberg,et al.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.

[21]  Paul F. Smith,et al.  The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). , 1996, Journal of ethnopharmacology.

[22]  Q. Dai,et al.  [Preliminary study on early fibrosis of chronic hepatitis B treated with Ginkgo biloba Composita]. , 1995, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[23]  M. Scaglia,et al.  Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii , 1993, Antimicrobial Agents and Chemotherapy.

[24]  A. Tamborini,et al.  [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome]. , 1993, Revue francaise de gynecologie et d'obstetrique.

[25]  D. Lebuisson,et al.  [Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study]. , 1986, Presse medicale.

[26]  V. Kusum Devi,et al.  Importance of novel drug delivery systems in herbal medicines , 2010, Pharmacognosy reviews.

[27]  S. Derenne,et al.  Evolution of the chemical composition of Ginkgo biloba external and internal leaf lipids through senescence and litter formation , 2001 .

[28]  S. Pietri,et al.  Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. , 1997, Cardiovascular drugs and therapy.

[29]  M. Klasser,et al.  Study of the long-term action of a Ginkgo biloba extract on vigilance and mental performance as determined by means of quantitative pharmaco-EEG and psychometric measurements. , 1985, Arzneimittel-Forschung.